AKT1 and cancer: Several studies have demonstrated novel mechanisms-of-action of these drugs in cancer cells including, but not limited to, inhibition of cytochrome c oxidase activity, disruptions of MAPK/ERK, AKT/PI3K, WNT pathways; increased autophagy, and inhibition of cancer stem cell behavior (10, 11, 13).